177 related articles for article (PubMed ID: 35340220)
1. Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity.
Zhang X; Li L; Huang S; Liao W; Li J; Huang Z; Huang Y; Lian Y
Oxid Med Cell Longev; 2022; 2022():5322929. PubMed ID: 35340220
[TBL] [Abstract][Full Text] [Related]
2. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
[TBL] [Abstract][Full Text] [Related]
3. Clinical implication and immunological landscape analyses of ANLN in pan-cancer: A new target for cancer research.
Zhang L; Wei Y; He Y; Wang X; Huang Z; Sun L; Chen J; Zhu Q; Zhou X
Cancer Med; 2023 Feb; 12(4):4907-4920. PubMed ID: 36030492
[TBL] [Abstract][Full Text] [Related]
4. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
5. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers.
Shi Y; Ma X; Wang M; Lan S; Jian H; Wang Y; Wei Q; Zhong F
Cancer Cell Int; 2022 May; 22(1):188. PubMed ID: 35568883
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker.
Liu K; Cui L; Li C; Tang C; Niu Y; Hao J; Bu Y; Chen B
Front Genet; 2022; 13():922472. PubMed ID: 35991576
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.
Zeng S; Yu X; Ma C; Song R; Zhang Z; Zi X; Chen X; Wang Y; Yu Y; Zhao J; Wei R; Sun Y; Xu C
Sci Rep; 2017 Jun; 7(1):3151. PubMed ID: 28600503
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers.
Cui Z; Mo J; Song P; Wang L; Wang R; Cheng F; Wang L; Zou F; Guan X; Zheng N; Yang X; Wang W
Front Genet; 2022; 13():1000339. PubMed ID: 36199577
[TBL] [Abstract][Full Text] [Related]
10. In silico analysis of expression pattern of a Wnt/β-catenin responsive gene ANLN in gastric cancer.
Pandi NS; Manimuthu M; Harunipriya P; Murugesan M; Asha GV; Rajendran S
Gene; 2014 Jul; 545(1):23-9. PubMed ID: 24809965
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of ANLN by lentivirus inhibits cell growth and migration in human breast cancer.
Zhou W; Wang Z; Shen N; Pi W; Jiang W; Huang J; Hu Y; Li X; Sun L
Mol Cell Biochem; 2015 Jan; 398(1-2):11-9. PubMed ID: 25223638
[TBL] [Abstract][Full Text] [Related]
12. Actin-binding protein Anillin promotes the progression of gastric cancer in vitro and in mice.
Jia H; Yu F; Li B; Gao Z
J Clin Lab Anal; 2021 Feb; 35(2):e23635. PubMed ID: 33089886
[TBL] [Abstract][Full Text] [Related]
13. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma.
Guo E; Mao X; Wang X; Guo L; An C; Zhang C; Song K; Wang G; Duan C; Zhang X; Yang X; Yuan Z; Sun J; Li X; Yang W; Meng H; Miao S
Cell Death Dis; 2021 Aug; 12(8):764. PubMed ID: 34344861
[TBL] [Abstract][Full Text] [Related]
14. MiR-16-5p suppresses breast cancer proliferation by targeting ANLN.
Wang Z; Hu S; Li X; Liu Z; Han D; Wang Y; Wei L; Zhang G; Wang X
BMC Cancer; 2021 Nov; 21(1):1188. PubMed ID: 34743685
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Anillin (ANLN) is correlated with colorectal cancer progression and poor prognosis.
Wang G; Shen W; Cui L; Chen W; Hu X; Fu J
Cancer Biomark; 2016; 16(3):459-65. PubMed ID: 27062703
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma.
Zhang LH; Wang D; Li Z; Wang G; Chen DB; Cheng Q; Hu SH; Zhu JY
Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):337-344. PubMed ID: 32933876
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive multiomics and in silico approach uncovers prognostic, immunological, and therapeutic roles of ANLN in lung adenocarcinoma.
Singh P; Arora S; Beg MA; Sahoo S; Nayek A; Khan MM; Sinha A; Malik MZ; Athar F; Serajuddin M; Dohare R; Syed MA
Funct Integr Genomics; 2023 Jul; 23(3):223. PubMed ID: 37410302
[TBL] [Abstract][Full Text] [Related]
18. Anillin is required for tumor growth and regulated by miR-15a/miR-16-1 in HBV-related hepatocellular carcinoma.
Lian YF; Huang YL; Wang JL; Deng MH; Xia TL; Zeng MS; Chen MS; Wang HB; Huang YH
Aging (Albany NY); 2018 Aug; 10(8):1884-1901. PubMed ID: 30103211
[TBL] [Abstract][Full Text] [Related]
19. ANLN Serves as an Oncogene in Bladder Urothelial Carcinoma via Activating JNK Signaling Pathway.
Chen S; Gao Y; Chen F; Wang TB
Urol Int; 2023; 107(3):310-320. PubMed ID: 35504258
[TBL] [Abstract][Full Text] [Related]
20. Genetic interactions between ANLN and KDR are prognostic for breast cancer survival.
Dai X; Chen X; Hakizimana O; Mei Y
Oncol Rep; 2019 Dec; 42(6):2255-2266. PubMed ID: 31578580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
